Oops! Something went wrong while submitting the form.
BNAO
August 14, 2020
185(7-8):e1065-e1072 | Macko A, Sheppard FR, Nugent WH, Abuchowski A, Song BK.
Improved Hemodynamic Recovery and 72-Hour Survival Following Low-Volume Resuscitation with a PEGylated Carboxyhemoglobin in a Rat Model of Severe Hemorrhagic Shock. Mil Med.
CYSTIC FIBROSIS
July 14, 2020
11:1059 | Di Pietro C, Öz HH, Murray TS, Bruscia EM.
Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. Front Pharmacol.
BNAO
June 1, 2020
33(3): 372-377 | McConachie S, Wahby K, Almadrahi Z, Wilhelm S.
Early Experiences With PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah's Witnesses: A Case Series and Review of the Literature. J Pharm Pract.
BNAO
May 1, 2020
318(5): F1271-F1283 | Guerci P, Ergin B, Kandil A, Ince Y, Heeman P, Hilty MP, Bakker J, Ince C.
Resuscitation with PEGylated carboxyhemoglobin preserves renal cortical oxygenation and improves skeletal muscle microcirculatory flow during endotoxemia. Am J Physiol Renal Physiol.
BNAO
February 8, 2020
153(3): 287-293 | Bachert SE, Dogra P, Boral LI.
Alternatives to Transfusion. Am J Clin Pathol.
OTHER
January 1, 2020
35(1):19-25 | Romito BT, McBroom MM, Bryant D, Gamez J, Merchant A, Hill SE.
The effect of SANGUINATE® (PEGylated carboxyhemoglobin bovine) on cardiopulmonary bypass functionality using a bovine whole blood model of normovolemic hemodilution. Perfusion.